Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age

Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age

Abstract Introduction Mechanistic target of rapamycin (mTOR) inhibitors sirolimus and everolimus are an effective therapy for subependymal giant cell astrocytomas, cardiac rhabdomyomas, renal angiomyolipomas, and lymphangioleiomyomatosis associated with tuberous sclerosis complex (TSC). Everolimus w...

Full description

Bibliographic Details
Main Authors: Dominika Śmiałek, Katarzyna Kotulska, Aleksandra Duda, Sergiusz Jóźwiak
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-04-01
Series:Neurology and Therapy
Subjects:
Children
Epilepsy
Everolimus
mTOR inhibitors
Seizures
Sirolimus
Online Access:https://doi.org/10.1007/s40120-023-00476-7

Internet

https://doi.org/10.1007/s40120-023-00476-7

Similar Items